These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2164640)

  • 1. The cytomegalovirus enhancer: a pan-active control element in transgenic mice.
    Schmidt EV; Christoph G; Zeller R; Leder P
    Mol Cell Biol; 1990 Aug; 10(8):4406-11. PubMed ID: 2164640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice.
    Baskar JF; Smith PP; Nilaver G; Jupp RA; Hoffmann S; Peffer NJ; Tenney DJ; Colberg-Poley AM; Ghazal P; Nelson JA
    J Virol; 1996 May; 70(5):3207-14. PubMed ID: 8627801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a cytomegalovirus IE-1-factor VIII cDNA hybrid gene in transgenic mice.
    Mikkelsen TR; Chapman B; Din N; Ingerslev J; Kristensen P; Poulsen K; Hjorth JP
    Transgenic Res; 1992 Jul; 1(4):164-9. PubMed ID: 1338694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and tissue-specific expression of human cytomegalovirus.
    Nelson JA; Gnann JW; Ghazal P
    Curr Top Microbiol Immunol; 1990; 154():75-100. PubMed ID: 2161326
    [No Abstract]   [Full Text] [Related]  

  • 5. Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element.
    Cherrington JM; Mocarski ES
    J Virol; 1989 Mar; 63(3):1435-40. PubMed ID: 2536844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid expression cassettes consisting of a milk protein promoter and a cytomegalovirus enhancer significantly increase mammary-specific expression of human lactoferrin in transgenic mice.
    Cheng Y; An LY; Yuan YG; Wang Y; Du FL; Yu BL; Zhang ZH; Huang YZ; Yang TJ
    Mol Reprod Dev; 2012 Aug; 79(8):573-85. PubMed ID: 22730016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice.
    Simonet WS; Bucay N; Lauer SJ; Taylor JM
    J Biol Chem; 1993 Apr; 268(11):8221-9. PubMed ID: 7681840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection.
    Koedood M; Fichtel A; Meier P; Mitchell PJ
    J Virol; 1995 Apr; 69(4):2194-207. PubMed ID: 7884867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a boundary domain adjacent to the potent human cytomegalovirus enhancer that represses transcription of the divergent UL127 promoter.
    Angulo A; Kerry D; Huang H; Borst EM; Razinsky A; Wu J; Hobom U; Messerle M; Ghazal P
    J Virol; 2000 Mar; 74(6):2826-39. PubMed ID: 10684299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice.
    Mehta AK; Majumdar SS; Alam P; Gulati N; Brahmachari V
    Gene; 2009 Jan; 428(1-2):20-4. PubMed ID: 18976699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cis repression sequence adjacent to the transcription start site of the human cytomegalovirus US3 gene is required to down regulate gene expression at early and late times after infection.
    Lashmit PE; Stinski MF; Murphy EA; Bullock GC
    J Virol; 1998 Dec; 72(12):9575-84. PubMed ID: 9811691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A strong negative transcriptional regulatory region between the human cytomegalovirus UL127 gene and the major immediate-early enhancer.
    Lundquist CA; Meier JL; Stinski MF
    J Virol; 1999 Nov; 73(11):9039-52. PubMed ID: 10516010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection.
    Isomura H; Stinski MF
    J Virol; 2003 Mar; 77(6):3602-14. PubMed ID: 12610136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental analysis of the cytomegalovirus enhancer in transgenic animals.
    Baskar JF; Smith PP; Ciment GS; Hoffmann S; Tucker C; Tenney DJ; Colberg-Poley AM; Nelson JA; Ghazal P
    J Virol; 1996 May; 70(5):3215-26. PubMed ID: 8627802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer.
    Gustems M; Borst E; Benedict CA; Pérez C; Messerle M; Ghazal P; Angulo A
    J Virol; 2006 Oct; 80(19):9899-904. PubMed ID: 16973595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a large bent DNA domain and binding sites for serum response factor adjacent to the NFI repeat cluster and enhancer region in the major IE94 promoter from simian cytomegalovirus.
    Chang YN; Jeang KT; Chiou CJ; Chan YJ; Pizzorno M; Hayward GS
    J Virol; 1993 Jan; 67(1):516-29. PubMed ID: 8380090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of a repetitive palindromic sequence element in the human cytomegalovirus major immediate early enhancer.
    Fickenscher H; Stamminger T; Rüger R; Fleckenstein B
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():107-23. PubMed ID: 2543734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNase I hypersensitive site maps to the HBV enhancer.
    Akmal M; el-Ghor A; Burk RD
    Virology; 1989 Oct; 172(2):478-88. PubMed ID: 2800333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spermatid-specific promoter of the SP-10 gene functions as an insulator in somatic cells.
    Reddi PP; Shore AN; Shapiro JA; Anderson A; Stoler MH; Acharya KK
    Dev Biol; 2003 Oct; 262(1):173-82. PubMed ID: 14512027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic regions regulating imprinting and insulin-like growth factor-II promoter 3 activity in transgenics: novel enhancer and silencer elements.
    Ward A; Fisher R; Richardson L; Pooler JA; Squire S; Bates P; Shaposhnikov R; Hayward N; Thurston M; Graham CF
    Genes Funct; 1997 Feb; 1(1):25-36. PubMed ID: 9680326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.